RecruitingNCT05178498

Impact of Dietary Inflammatory Potential on Breast Cancer Risk

Longitudinal Study Evaluating the Impact of Dietary Inflammatory Potential on Breast Cancer Risk in a Cohort of Women Followed in the Breast Cancer Prevention Clinic at the Ohio State University Comprehensive Cancer Center- James Cancer Hospital and Solove Research Institute


Sponsor

Ohio State University Comprehensive Cancer Center

Enrollment

960 participants

Start Date

Oct 25, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

This study evaluates the association of dietary inflammatory potential with breast cancer risk. Information collected in this study may help doctors to identify modifiable risk factors, screen high risk patients early, improve prevention strategies, and provide timely intervention for early therapeutic management as needed.


Eligibility

Min Age: 18 Years

Inclusion Criteria6

  • Age \>= 18 years
  • Established in the high risk clinic at OSUCCC- James (includes patients with family history of breast cancer \[BC\], known genetic predisposition, personal history of known atypia/breast lobular carcinoma in situ \[LCIS\], or prior chest wall radiation)
  • Patients at high risk for BC established in the surgical oncology clinic at Stefanie Spielman Comprehensive Breast Center (SSCBC), with one of the following diagnoses: Atypical ductal hyperplasia (ADH), atypical lobular hyperplasia (ALH), lobular carcinoma in situ (LCIS), sclerosing adenosis (SA), or radial scars (RS)
  • Able to read and understand English
  • Able to provide informed consent
  • Must consent to continued follow-up of medical records during the study period

Exclusion Criteria3

  • Prisoners
  • Not able to speak and understand English
  • Known personal history of ductal carcinoma in situ (DCIS) or Invasive BC

Interventions

PROCEDUREFollow-Up

Undergo follow up

PROCEDUREPhysical Examination

Complete physical measurements

OTHERQuestionnaire Administration

Complete questionnaires


Locations(1)

Ohio State University Comprehensive Cancer Center

Columbus, Ohio, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05178498


Related Trials